The lung microbiome and ICS: Influence of airway inflammation on COPD treatment

Dr Richard Russell is joined this week by Professor James Chalmers, the Asthma and Lung UK Chair of Respiratory Research at the University of Dundee, Scotland, and Honorary consultant physician at Ninewells Hospital, to discuss the role of the lung microbiome in respiratory disease and the influence it may have on the management of COPD.^1–3 Dr Russell will then share insights from an interesting new editorial which explores strategies implemented in the management of chronic respiratory disease in Finland from 1996–2018. ⁴ Finally, we delve into the social media hot topic of the week: advance care planning in COPD. Be sure to subscribe to the Medical Insider COPD podcast and never miss an episode!

^1. Global Initiative for Chronic Obstructive Lung Disease 2022. Available at: here Last accessed: September 2022
^2. Keir H, Contoli M, and Chalmers JD. Biomedicines 2021;9:1312;
^3. Keir H, et al. Am J Respir Crit Care Med 2022;205:A5567;
^4. Tiina M, et al. Eur Respir J 2022;60:2200318

Disclosures
Professor James Chalmers
Professor James Chalmers has received consultancy fees from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Grifols, Insmed, Janssen, Novartis and Zambon. He has also received research grant support from AstraZeneca, Boehringer Ingelheim, Gilead Sciences, GlaxoSmithKline, Insmed and Novartis.

Bios:

Professor James Chalmers
Professor James Chalmers is the Asthma and Lung UK Chair of Respiratory Research at the University of Dundee, Scotland, and an Honorary consultant physician at Ninewells Hospital. His clinical and research interests are in difficult airways diseases, particularly bronchiectasis and COPD. He chaired the 2017 European Respiratory Society bronchiectasis guidelines and was also involved with 2020 Guidelines on inhaled corticosteroid use in COPD and the 2021 COVID-19 management guidelines. He is also deputy chief editor of the European Respiratory Journal and a member of the Editorial Board for the Medical Insider COPD Podcast series.

This series of podcasts are intended for healthcare professionals only.

The Medical Insider COPD podcast series discusses hot topics in the world of COPD with those who know it best, aiming to spread information, debunk myths and improve the lives of patients. The Editorial Board of the Medical Insider COPD podcast is comprised of Professor James Chalmers, the British Lung Foundation Chair of Respiratory Research at the University of Dundee (UK), Professor Michael Dreher, the Head of the Department of Pneumology and Intensive Care Medicine at the University Hospital Aachen (Germany), and the host and moderator, Dr Richard Russell, a Consultant Chest Physician at Lymington New Forest Hospital (UK), a Senior Clinical Researcher at the University of Oxford (UK) and the founding editor of the International Journal of COPD. These series of podcasts have not been peer-reviewed, but have been vetted by the journal’s Editor-in-Chief.